Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Biosense Webster launches AF (atrial flutter) ablation catheter

This article was originally published in Clinica

Executive Summary

Biosense Webster has launched for sale in the US what it claims is the first FDA-cleared dual sensor 8mm tip ablation catheter for treating atrial flutter (AF). The Navistar DS catheter, which showed clinical efficacy in the acute and six-month follow-up settings of 98.8% and 96.7%, provides benefits over conventional 4mm catheters, says the firm.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT068549

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel